Twice- or Once-Daily Dosing of Novel Oral Anticoagulants for Stroke Prevention: A Fixed-Effects Meta-Analysis with Predefined Heterogeneity Quality Criteria

BACKGROUND: A number of novel oral anticoagulants (direct thrombin inhibitors or factor Xa inhibitors) are in clinical use for various indications. The dosing regimens differ between twice-daily and once-daily dosing for the prevention of stroke in patients with atrial fibrillation. With the availab...

Descripción completa

Detalles Bibliográficos
Autores principales: Clemens, Andreas, Noack, Herbert, Brueckmann, Martina, Lip, Gregory Y. H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4049736/
https://www.ncbi.nlm.nih.gov/pubmed/24911432
http://dx.doi.org/10.1371/journal.pone.0099276

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4049736/
https://www.ncbi.nlm.nih.gov/pubmed/24911432
http://dx.doi.org/10.1371/journal.pone.0099276

Ejemplares similares